The same study found that the most common reasons patients stop GLP-1 therapy are adverse effects (52%), medication shortages (33%), and cost (25%)
Pinch a fold of skin between your thumb and index finger
I'm not craving carbs
Rarely are the drugs anticipated side effects which include headache, nausea, vomiting, and decreased blood glucose (3032)
Future algorithms will pull data from wearables, meal logs, and gut hormone assays
What are the considerations for using GLP-1 (Glucagon-like peptide-1) receptor agonists, such as liraglutide (Victoza) or semaglutide (Ozempic), in a patient with chronic Hepatitis B, fatty liver disease, and hypothyroidism on levothyroxine (T4) therapy?